Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Francesca GottardiFrancesco BaccelliDavide LeardiniAntonia Di BattistaPaolo CastellucciDomenico D'AmicoSalvatore SerravalleSalvatore Nicola BertuccioDaria MesselodiArcangelo PreteRiccardo MasettiPublished in: British journal of haematology (2023)